IL6 and Cachexia: With this data in mind, along with the previously established connections between IL-6 and cachexia, care must be taken when designing chemotherapy regimens in order to prevent possible acceleration of cachexia, especially in patients who present with low skeletal muscle mass, resulting in poorer outcomes and decreased survival.